DEPHLAGY is the first Artificial Intelligence driven cybersecurity program utilizing DLT to increase the accuracy of its health check. Using machine learning and probabilistic mathematics, we plan to offer a security system that is ever-alert, always present and device agnostic.
DEPHLAGY intends to target major industries by creating partnerships with security vendors for immutable compliance and investigation. DEPHLAGY will also target hardware and software vendors to integrate the distributed ledger within IoT devices and enterprise networks for monitoring and mitigation services through our patent-pending system health check. Our market focus breaks down into three distinct categories:
Monitoring IoT devices and systems Threat mitigation of IoT devices and systems Auditing and compliance for threat monitoring platformsQ1 2018
Q2 2019
Q4 2019
Q1 2020
Q1 2020
Q2 2020
Q3 2020
Q3 2020
q4 2020
Verified 0%
Attention. There is a risk that unverified members are not actually members of the team
This offer is based solely on information provided by the offeror and other publicly available sources.
The token sale or exchange event is completely independent of ICOholder. ICOholder is not involved in any way, including technical support or promotion.
We list token sales from entities with which we have no relationship to help users track overall activity within the token sector. This information is not intended as advice, and you should seek professional or specialist guidance or conduct your own due diligence before making any decisions based on our content.
Any terms and conditions regarding token acquisition are solely between contributors and the token issuer. ICOholder is not the seller of these tokens.
ICOholder is not legally responsible for any representations made by third parties about any token sale. Any claims for breach of contract must be directed against the listed token issuing entity.
If you have concerns about the nature, legality, or propriety of a token sale or the involved individuals, please contact info@icoholder.com with detailed information.